HEADER TRANSPORT PROTEIN 17-APR-14 4Q5T TITLE CRYSTAL STRUCTURE OF AN ATMB (PUTATIVE MEMBRANE LIPOPROTEIN) FROM TITLE 2 STREPTOCOCCUS MUTANS UA159 AT 1.91 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: LIPOPROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 24-280; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOCOCCUS MUTANS UA159; SOURCE 3 ORGANISM_TAXID: 210007; SOURCE 4 STRAIN: ATCC 700610 / UA159; SOURCE 5 GENE: ATMB, SMU_1941; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: PB1; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS METHIONINE-BINDING, NLPA LIPOPROTEIN, PF03180 FAMILY, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-BIOLOGY, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 3 01-FEB-23 4Q5T 1 REMARK SEQADV LINK REVDAT 2 22-NOV-17 4Q5T 1 REMARK REVDAT 1 18-JUN-14 4Q5T 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF AN ATMB (PUTATIVE MEMBRANE LIPOPROTEIN) JRNL TITL 2 FROM STREPTOCOCCUS MUTANS UA159 AT 1.91 A RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.8.2 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.78 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.220 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 23128 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.183 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.140 REMARK 3 FREE R VALUE TEST SET COUNT : 1189 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.7805 - 3.8108 0.99 2894 137 0.1720 0.1890 REMARK 3 2 3.8108 - 3.0258 0.99 2755 149 0.1668 0.2455 REMARK 3 3 3.0258 - 2.6436 1.00 2755 158 0.1741 0.2237 REMARK 3 4 2.6436 - 2.4020 1.00 2743 153 0.1648 0.2211 REMARK 3 5 2.4020 - 2.2299 0.99 2710 150 0.1815 0.2352 REMARK 3 6 2.2299 - 2.0985 1.00 2742 140 0.1966 0.2595 REMARK 3 7 2.0985 - 1.9934 0.99 2655 155 0.2362 0.2989 REMARK 3 8 1.9934 - 1.9070 0.98 2685 147 0.2941 0.2929 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.210 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.68 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.45 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.012 2103 REMARK 3 ANGLE : 1.239 2830 REMARK 3 CHIRALITY : 0.072 319 REMARK 3 PLANARITY : 0.005 358 REMARK 3 DIHEDRAL : 16.777 813 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): 16.1157 37.3778 37.3935 REMARK 3 T TENSOR REMARK 3 T11: 0.2627 T22: 0.2262 REMARK 3 T33: 0.2316 T12: 0.0051 REMARK 3 T13: 0.0313 T23: -0.0008 REMARK 3 L TENSOR REMARK 3 L11: 0.0729 L22: 0.6194 REMARK 3 L33: 1.6865 L12: -0.1657 REMARK 3 L13: 0.2717 L23: 0.9582 REMARK 3 S TENSOR REMARK 3 S11: -0.0608 S12: 0.0301 S13: 0.0402 REMARK 3 S21: 0.1291 S22: -0.0620 S23: 0.0894 REMARK 3 S31: 0.5374 S32: 0.0357 S33: -0.0179 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. ZERO OCCUPANCY HYDROGENS WERE REMARK 3 INCLUDED DURING REFINEMENT TO IMPROVE THE ANTI-BUMPING REMARK 3 RESTRAINTS. 2. ATOM RECORDS CONTAIN SUM OF TLS AND RESIDUAL B REMARK 3 FACTORS. 3. ANISOU RECORDS CONTAIN SUM OF TLS AND RESIDUAL U REMARK 3 FACTORS. 4. A MET-INHIBITION PROTOCOL WAS USED FOR REMARK 3 SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE REMARK 3 OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO REMARK 3 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. 5. LIGAND SELENOMETHIONINE HAS BEEN MODELED BASED REMARK 3 ON DENSITY AND ANOMALOUS DIFFERENCE FOURIER MAP. 6. NONAETHYLENE REMARK 3 GLYCOL (2PE) MOLECULES FROM THE CRYSTALLIZATION SOLUTION ARE REMARK 3 MODELED. REMARK 4 REMARK 4 4Q5T COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-APR-14. REMARK 100 THE DEPOSITION ID IS D_1000085640. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979068,0.979338,0.953725 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : KOHZU: DOUBLE CRYSTAL SI(111) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE MARCH 15, 2012 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23167 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.910 REMARK 200 RESOLUTION RANGE LOW (A) : 28.777 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.05700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1100 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.91 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.44800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: MAD REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: SHELX, SHARP, SHELXD REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.200M SODIUM CHLORIDE, 50.00% REMARK 280 POLYETHYLENE GLYCOL 400, 0.0100M BARIUM CHLORIDE, 0.1M CHES PH REMARK 280 9.5, NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.61000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.61000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.01050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 53.02650 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.01050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 53.02650 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 47.61000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.01050 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 53.02650 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 47.61000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.01050 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 53.02650 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CRYSTAL PACKING ANALYSIS SUGGESTS THE ASSIGNMENT OF A REMARK 300 MONOMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 535 LIES ON A SPECIAL POSITION. REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 56 CG CD CE NZ REMARK 470 LYS A 97 CD CE NZ REMARK 470 LYS A 100 CG CD CE NZ REMARK 470 ASP A 168 CG OD1 OD2 REMARK 470 GLU A 228 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 525 O HOH A 526 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 86 -10.94 -158.32 REMARK 500 THR A 109 -89.01 -121.11 REMARK 500 HIS A 260 53.56 -90.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 2PE A 301 REMARK 610 2PE A 302 REMARK 610 2PE A 303 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2PE A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2PE A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2PE A 303 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: JCSG-417498 RELATED DB: TARGETTRACK REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT WAS EXPRESSED WITH AN N-TERMINAL PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY RESIDUES 25-280 OF THE TARGET REMARK 999 SEQUENCE. DBREF 4Q5T A 25 280 UNP I6L927 I6L927_STRMU 25 280 SEQADV 4Q5T GLY A 0 UNP I6L927 EXPRESSION TAG SEQRES 1 A 257 GLY GLN LYS ASN ASP LYS ASN THR LEU THR VAL GLY VAL SEQRES 2 A 257 MSE THR MSE THR ASP SER ASP LYS GLU ARG TRP ASP LYS SEQRES 3 A 257 ILE GLU GLU LEU LEU LYS LYS GLU ASN ILE LYS LEU LYS SEQRES 4 A 257 PHE LYS GLU PHE THR ASP TYR SER GLN PRO ASN LYS ALA SEQRES 5 A 257 LEU LYS ASN GLY GLU ILE ASP ILE ASN SER PHE GLN HIS SEQRES 6 A 257 TYR ASN PHE LEU ASN ASN TRP ASN LYS GLU ASN LYS GLY SEQRES 7 A 257 ASP LEU VAL THR VAL ALA GLU THR TYR ILE SER PRO ILE SEQRES 8 A 257 ASN LEU PHE SER GLY THR GLU ASN GLY LYS ALA LYS TYR SEQRES 9 A 257 SER SER ALA LYS GLU ILE PRO ASN GLY GLY GLN ILE ALA SEQRES 10 A 257 ILE PRO ASN ASP ALA THR ASN GLU SER ARG ALA LEU TYR SEQRES 11 A 257 VAL LEU GLN ASP ALA GLY LEU ILE LYS LEU ASN VAL SER SEQRES 12 A 257 GLY ASP GLU LEU ALA THR VAL LYS ASN ILE LYS SER ASN SEQRES 13 A 257 PRO LYS ASN LEU ASP ILE LYS GLU VAL ASP ALA SER GLN SEQRES 14 A 257 THR ALA ARG ASN LEU ALA SER VAL ASP ALA ALA VAL VAL SEQRES 15 A 257 ASN ASN SER TYR ALA VAL PRO ALA LYS ILE ASP PHE LYS SEQRES 16 A 257 THR SER LEU TYR LYS GLU LYS VAL ASN GLU GLY SER LYS SEQRES 17 A 257 GLN TRP ILE ASN ILE ILE ALA ALA GLN LYS ASN TRP LYS SEQRES 18 A 257 LYS SER LYS LYS ALA ALA ALA ILE LYS LYS LEU ILE LYS SEQRES 19 A 257 ALA TYR HIS THR ASP ALA VAL LYS LYS VAL ILE LYS LYS SEQRES 20 A 257 THR ALA LYS GLY VAL ASP GLU PRO VAL TRP MODRES 4Q5T MSE A 37 MET SELENOMETHIONINE MODRES 4Q5T MSE A 39 MET SELENOMETHIONINE HET MSE A 37 8 HET MSE A 39 8 HET MSE A 300 9 HET 2PE A 301 16 HET 2PE A 302 14 HET 2PE A 303 10 HETNAM MSE SELENOMETHIONINE HETNAM 2PE NONAETHYLENE GLYCOL FORMUL 1 MSE 3(C5 H11 N O2 SE) FORMUL 3 2PE 3(C18 H38 O10) FORMUL 6 HOH *154(H2 O) HELIX 1 1 GLY A 0 ASP A 28 5 5 HELIX 2 2 THR A 40 LYS A 56 1 17 HELIX 3 3 GLN A 71 ASN A 78 1 8 HELIX 4 4 TYR A 89 LYS A 100 1 12 HELIX 5 5 SER A 129 ILE A 133 5 5 HELIX 6 6 ASP A 144 ALA A 158 1 15 HELIX 7 7 THR A 172 LYS A 174 5 3 HELIX 8 8 ASP A 189 SER A 191 5 3 HELIX 9 9 GLN A 192 LEU A 197 1 6 HELIX 10 10 ASN A 206 VAL A 211 1 6 HELIX 11 11 ASP A 216 LYS A 218 5 3 HELIX 12 12 ASN A 227 GLN A 232 5 6 HELIX 13 13 ASN A 242 SER A 246 5 5 HELIX 14 14 LYS A 248 HIS A 260 1 13 HELIX 15 15 THR A 261 LYS A 273 1 13 SHEET 1 A 6 LYS A 60 PHE A 66 0 SHEET 2 A 6 THR A 31 MSE A 37 1 N VAL A 34 O LYS A 62 SHEET 3 A 6 ILE A 83 HIS A 88 1 O SER A 85 N GLY A 35 SHEET 4 A 6 ILE A 234 ALA A 239 -1 O ILE A 236 N GLN A 87 SHEET 5 A 6 VAL A 104 ILE A 111 -1 N TYR A 110 O ASN A 235 SHEET 6 A 6 GLU A 277 PRO A 278 -1 O GLU A 277 N ILE A 111 SHEET 1 B 5 ASP A 184 VAL A 188 0 SHEET 2 B 5 GLN A 138 PRO A 142 1 N ILE A 141 O VAL A 188 SHEET 3 B 5 ALA A 202 VAL A 205 1 O VAL A 204 N ALA A 140 SHEET 4 B 5 ASN A 115 SER A 118 -1 N PHE A 117 O ALA A 203 SHEET 5 B 5 SER A 220 LYS A 223 -1 O LEU A 221 N LEU A 116 SHEET 1 C 2 THR A 120 GLU A 121 0 SHEET 2 C 2 LYS A 124 ALA A 125 -1 O LYS A 124 N GLU A 121 SHEET 1 D 2 LYS A 162 LEU A 163 0 SHEET 2 D 2 ILE A 176 SER A 178 -1 O LYS A 177 N LYS A 162 LINK C VAL A 36 N MSE A 37 1555 1555 1.33 LINK C MSE A 37 N THR A 38 1555 1555 1.33 LINK C THR A 38 N MSE A 39 1555 1555 1.33 LINK C MSE A 39 N THR A 40 1555 1555 1.33 SITE 1 AC1 5 ASP A 216 PHE A 217 LYS A 218 LYS A 273 SITE 2 AC1 5 VAL A 275 SITE 1 AC2 8 LYS A 77 ASP A 102 LYS A 126 GLY A 136 SITE 2 AC2 8 SER A 199 GLN A 240 ASN A 242 HOH A 543 SITE 1 AC3 4 ALA A 194 ALA A 213 LYS A 214 HOH A 527 CRYST1 58.021 106.053 95.220 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017235 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009429 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010502 0.00000